Antimalarials

Last updated: September 16, 2025

Antimalarials

Pharma

Pharma

Introduction to pharmacology
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacodynamics: Desensitization and tolerance
Cholinergic receptors
Adrenergic receptors
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Sympathomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Monoamine oxidase inhibitors
Atypical antidepressants
Typical antipsychotics
Atypical antipsychotics
Lithium
Nonbenzodiazepine anticonvulsants
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Psychomotor stimulants
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Positive inotropic medications
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Antihistamines for allergies
Acid reducing medications
Laxatives and cathartics
Antidiarrheals
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Glucocorticoids
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Mechanisms of antibiotic resistance
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Osteoporosis medications
General anesthetics
Local anesthetics
Neuromuscular blockers
Anti-parkinson medications
Medications for neurodegenerative diseases
Opioid antagonists
Osmotic diuretics
Carbonic anhydrase inhibitors
Loop diuretics
Potassium sparing diuretics
Androgens and antiandrogens
PDE5 inhibitors
Estrogens and antiestrogens
Progestins and antiprogestins
Aromatase inhibitors
Uterine stimulants and relaxants
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors

Transcript

Watch video only

Malaria is an infection that can be caused by a few different types of plasmodium species, which are single-celled parasites that are spread by mosquitoes. There are hundreds of types of Plasmodium species, but the five that cause malarial disease in humans are Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale, and Plasmodium knowlesi. Once the plasmodium gets into the bloodstream, it infects liver cells and red blood cells, which causes a variety of symptoms and sometimes even leads to death. We rely on groups of medications commonly known as antimalarials, in order to prevent and treat malaria.

Now, malaria is transmitted when a plasmodium-infected female of the Anopheles mosquito hunts for a blood meal in the evening and throughout the night. They’re kind of like tiny flying vampires, with the mosquito being drawn to carbon dioxide that gets breathed out, as well as bodily smells, like foot odor. At this point, the Plasmodium is in a stage of development called a sporozoite, waiting patiently in the mosquito’s salivary gland.

When the mosquito bites a person with its proboscis, the worm-like sporozoites spill out of the mosquito’s saliva and make it into the bloodstream. The sporozoites then travel to the liver, where they invade hepatocytes.

There, they begin asexual reproduction, also known as schizogony. Over the next 1-2 weeks, P. falciparum, P. malariae, and P. knowlesi sporozoites multiply asexually and mature into merozoites, while host hepatic parenchymal cells die. In contrast, Plasmodium vivax and Plasmodium ovale sporozoites enter into a dormant hepatic phase, where they are called hypnozoites. They can remain in this dormant phase for months to years until they wake up and begin schizogony.

In both cases, when the merozoites are released into the blood, they enter the erythrocytic phase, where they invade red blood cells. Once inside the red blood cell, Plasmodium feeds on hemoglobin via a process called endocytosis, where the parasite wraps its membrane around the hemoglobin, in order to bring the hemoglobin inside itself. The plasma membrane forms a bubble called a food vacuole where hemoglobin can be broken down. Plasmodium uses the globin proteins to fuel their growth, but the heme is toxic to them, so they are converted into insoluble hemozoin crystals. As the parasite feeds, it undergoes mitosis and differentiates into lots of merozoites, which then burst out of the red blood cell and enter back into circulation.

Now, instead of going into the erythrocytic phase again, some of the merozoites undergo gametogony, which is where they divide and give rise to gametocytes, which are little sausage -shaped sexual forms that can be either male or female. These gametocytes remain inside of a red blood cell, and can get sucked up by another female mosquito that bites the same malaria carrier.

The gametocytes can then fuse together inside the mosquito to form a zygote. This part of the plasmodium life cycle is called sporogony, and it’s sexual reproduction, as opposed to the schizogony or asexual reproduction that happened in the liver and red blood cells. The zygote then goes on to develop further, it becomes an ookinete and then an oocyst that ruptures in the mosquito’s gut, releasing thousands of sporozoites, which navigate their way into the mosquito's salivary gland in order to repeat the cycle all over again.

Symptoms of malaria correspond to the reproductive cycle that is unique for each plasmodium species. When the red blood cells burst at the end of the erythrocytic phase, tumor necrosis factor alpha and other inflammatory cytokines are released, which causes high fevers that typically occur in paroxysms or short bursts.

For example, Plasmodium malariae, fevers happen every 72 hours, and is called quartan fever, while for Plasmodium vivax and Plasmodium ovale, fevers happen every 48 hours, and these are called tertian fever. Now, since red blood cells are destroyed when merozoites are released, malaria also causes hemolytic anemia, with symptoms like extreme fatigue, headaches, jaundice, and splenomegaly.

Now, many of the antimalarial medications are quinoline derivatives like quinine, which is one of the earliest antimalarial medications derived from the bark of South American Cinchona trees. Other medications in this class include quinidine, chloroquine, mefloquine, and primaquine. These medications work by entering the plasmodium and accumulating in their food vacuoles. Here, they bind to heme and prevent it from being converted into hemozoin. Since heme is toxic to the Plasmodium, this eventually leads to their death.

Key Takeaways

Antimalarials are a class of drugs used to treat or prevent malaria. Malaria is caused by parasites belonging to the plasmodium species, and can be deadly if not treated quickly. Antimalarial drugs work by killing these parasites that cause the disease. There are different types of antimalarials usually taken as pills or injections. Common brands include artemisinin, chloroquine, quinine sulfate, doxycycline, and quinine. Antimalarial drugs are effective at treating malaria, but they can have various side effects depending on the drug.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum" Nature Communications (2015)
  5. "Tetracyclines Specifically Target the Apicoplast of the Malaria Parasite Plasmodium falciparum" Antimicrobial Agents and Chemotherapy (2006)